Epilepsy Drug Development: How Patients Can Make An Impact

Have you ever thought about taking part in a clinical trial for a new epilepsy therapy? Patients’ participation in clinical trials is essential to the development of new treatments for epilepsy. Researchers depend on patient participation to guide them in the creation of safe, effective, and improved therapies for epilepsy. Volunteering for a trial is the most direct way for epilepsy patients to impact the science that will lead us to a cure. But there are questions to ask and things you need to know before you consider participating. We lay it all out for you in the new episode of Seizing Life.

In the third part of our 4-part series exploring the drug development process, we explore the importance of clinical trial participation with Dr. Darcy Krueger, Director of the Tuberous Sclerosis Clinic and Associate Professor of Clinical Pediatrics and Neurology at Cincinnati Children’s Hospital Medical Center. Dr. Krueger discusses the importance of clinical trials and explains what patients need to know before participating. From finding trials, to understanding protocols, requirements and legal rights, to setting expectations and receiving results, Dr. Krueger provides an instructive and insightful roadmap for patients to engage in clinical trials. If you’ve ever wondered what you can do to help push epilepsy research forward, this is a great place to start!

Want to download this episode? Fill out the form below and enjoy the podcast any time you’d like!